Vol. 11 No. 1 (2019): Archives of Public Health
Case Report

Tay Sachs disease-case report

Igor Isjanovski
Clinic for eye diseases; Medical Faculty, University Ss. Cyril and Methodius, Skopje, Republic of North Macedonia
Milena Golubovik Arsovska
Clinic for eye disease; Medical Faculty, University Ss. Cyril and Methodius, Skopje, Republic of North Macedonia

Published 2019-04-06


  • Tay Sachs's disease,
  • infant

How to Cite

Isjanovski I, Golubovik Arsovska M. Tay Sachs disease-case report. Arch Pub Health [Internet]. 2019 Apr. 6 [cited 2024 Apr. 23];11(1):110-3. Available from: https://id-press.eu/aph/article/view/2863


Tay Sachs's disease is a rare disorder, genetically inherited from parents of a child. It is caused by the absence of an enzyme that helps dissolve the fatty substances. These fatty substances, called gangliosides, rise to toxic levels in the child's brain and affect the function of nerve cells. By progressing the disease, the child loses muscle control. Eventually, it leads to blindness, paralysis and death.Most often, the newborn begins to show symptoms at the age of about 6 months. Signs and symptoms of Tay Sachs' disease can be: loss of motor skills, loss of ability to overturn, sitting or crawling. Then there are seizures, loss of hearing and inability to move, increased reactions when the baby hears loud noises, loss of visual acuity, the appearance of "Cherry-red" spots in the eyes, muscle weakness. 


Download data is not yet available.


  1. Tay Sachs Disease, Genetics Home Reference, 2012.
  2. Tay Sachs Disease, NORD (National Organization for Rare Disorders), 2017.
  3. Marinetti GV. Disorders of lipid metabolism. Springer Science & Business Media, 2012, p. 205.
  4. Walker J. Tay-Sachs Disease.The Rosen Publishing Group, 2007, p. 53.
  5. Hechtman P, Kaplan F. Tay-Sachs disease screening and diagnosis: Evolving technologies. DNA and Cell Biology 1993, 12 (8): 651–665.
  6. National Institute of Neurological Disorders and Stroke. Tay–Sachs disease Information Page, 2011.
  7. Tittarelli R, Giagheddu M, Spadetta V. Typical ophthalmoscopic picture of "cherry-red spot" in an adult with the myoclonic syndrome. The British Journal of Ophthalmology 1966; 50 (7): 414–420.
  8. Aragão RE, Ramos RM, Pereira FB, Bezerra AF, Fernandes DN. 'Cherry red spot' in a patient with Tay–Sachs disease: case report. Arq Bras Oftalmol 2009; 72 (4): 537–9.
  9. Seshadri R, Christopher R, Arvinda HR. Teaching NeuroImages: MRI in infantile Sandhoff disease. Neurology 2011; 77 (5): e34.
  10. Stoller D. Prenatal genetic screening: the enigma of selective abortion. Journal of Law and Health 1997; 12 (1): 121–140.
  11. ttps://www.mayoclinic.org/diseases-conditions/tay-sachs-disease/diagnosis-treatment/drc-20378193
  12. United States Center for Disease Control. Chorionic villus sampling and amniocentesis: recommendations for prenatal counseling. 2009. Available at https://www.cdc.gov/mmwr/preview/mmwrhtml/00038393.htm
  13. Bodurtha J, Strauss JF. Genomics and perinatal care. N Engl J Med 2012; 366(1):64–73.
  14. Marik JJ. Preimplantation Genetic Diagnosis. 2005. Available at: eMedicine.com.
  15. Ekstein J, Katzenstein H. The Dor Yeshorim story: Community-based carrier screening for Tay–Sachs disease. Adv Genet 2001; 44 (297–310).